Abstract
The NCCN Guidelines for Squamous Cell Skin Cancer provide recommendations for diagnostic workup, clinical stage, and treatment options for patients with cutaneous squamous cell carcinoma. The NCCN panel meets annually to discuss updates to the guidelines based on comments from panel members and the Institutional Review, as well as submissions from within NCCN and external organizations. These NCCN Guidelines Insights focus on the introduction of a new surgical recommendation terminology (peripheral and deep en face margin assessment), as well as recent updates on topical prophylaxis, immunotherapy for regional and metastatic disease, and radiation therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 1382-1394 |
| Number of pages | 13 |
| Journal | Journal of the National Comprehensive Cancer Network : JNCCN |
| Volume | 19 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Carcinoma, Squamous Cell/diagnosis
- Epithelial Cells
- Humans
- Immunotherapy
- Skin Neoplasms/diagnosis
Fingerprint
Dive into the research topics of 'Squamous Cell Skin Cancer, Version 1.2022 Featured Updates to the NCCN Guidelines: Squamous Cell Skin Cancer, Version 1.2022'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver